PPII Coenzyme A Inc (CE)

Pro-Pointer, Inc. (PINKSHEETS: PPII), through it's wholly owned subsidiary Coenzyme-A Technologies, Inc., is pleased to announce they are continuing the international distribution negotiations with Global Pharmaceuticals and Medical Supplies (GPMS), a new company that promises to be a leading exporter of American made pharmaceutical products and health and beauty supplies to the Middle Eastern and North African (MENA) countries within the next five years. They are confident that they can accomplish their goals by being the sole representing agent for carefully selected American supply manufacturers, which includes Coenzyme-A Technologies, Inc.

The proposed marketing Plan for 2010 by Global Pharmaceuticals and Medical Supplies (GPMS) demonstrates that the MENA region is part of the ever growing emerging markets and the total targeted population consists of 412.1 million consumers. Based on these demographics this marketing plan demonstrates great expansion opportunity for new companies based especially on its high growth rate and the high demand for quality made American products.

Global Pharmaceuticals (GPMS) possesses great knowledge of the Middle Eastern and North African region (MENA market which consists of about 17 countries) and its common attributes are that they are able to provide a better understanding and analysis of the major trends in those regions markets which therefore enables them to provide better service and communication to their targeted customer base.

Given the above statistics of the proposed market value of the MENA region, which includes the ever growing demand for quality Nutraceuticals, the company's proprietary "Pure Coenzyme-A" development represents tremendous future sales. This could easily translate to approximately over $10,000,000.00 in sales alone from this pending business transaction during the course of their proposed marketing plan.

ABOUT COENZYME-A TECHNOLOGIES, INC. - Coenzyme-A Technologies, Inc. is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the deleterious effects of aging. Coenzyme-A is the first nutraceutical product to combine nutritional components that can be successfully used by the body to support its manufacture and utilization of cellular Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific set of substrates that are designed to assist the body in converting fats, carbohydrates and proteins into energy at the cellular level. See Company website -- www.coenzyme-a.com.

FORWARD-LOOKING STATEMENTS The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Contact Information: Pro-Pointer, Inc. 458 Coral Sea St., Henderson, Nv. 89074 Ph- 702-458-4111 Cell-702-591-7440